Orchid Chemicals & Pharmaceuticals’ board of directors at its meeting held on March 14, 2014, has accepted the Letter of Approval (LOA) issued by Corporate Debt Restructuring Empowered Group (CDR EG) and approved the Corporate Debt Restructuring proposal submitted by the Company.
Orchid Chemicals & Pharmaceuticals is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. The company was incorporated in the year 1992 as a 100% export-oriented unit (EOU).
